The latest study by Bain & Company reveals that venture capital investment reached $89 billion globally (spread across more than 4,600 transactions) during the first quarter of 2024, representing a 16% increase compared to the last quarter of 2023. The consulting firm notes that generative artificial intelligence (AI) continues to dominate the venture capital landscape, given that large language models have a high need for funding.
According to the report, the United States led this growth, with a 72% increase compared to the previous quarter, driven by investments in technology, AI, energy, and healthcare. China also recorded a quarter-on-quarter increase of 13%, mainly due to the automotive and AI sectors. In contrast, Europe experienced a 28% decline in funding due to macroeconomic uncertainty and the technical recession in the United Kingdom.
The average size of venture capital deals increased across all funding stages. Early-stage investments grew by 43%, while seed-stage deals rose by 17%. In late-stage deals, the increase was 21%. Bain & Company particularly highlights the growth of Series B stage deals – when companies seek to expand their market reach – driven by sectors such as AI, renewable energy, and healthcare.
Additionally, the study indicates that while the number of Corporate Venture Capital investors remained stable, the deals funded by these investment vehicles increased significantly in the first quarter of 2024. This growth was particularly notable in the early-stage and seed stages, especially in sectors like energy, AI, and healthcare.
Alvaro Pires, partner at Bain & Company, adds: “More and more non-tech private equity firms are joining the generative AI trend. LG Technology Ventures, CVS Health Ventures, and Capital One Ventures led this activity globally in the past year. Moreover, we have observed significant growth in the collaborations these companies establish with some startups to incorporate generative AI into their customer experience.”